Effectiveness of a new decolonisation regimen for eradication of extended-spectrum β-lactamase-producing Enterobacteriaceae

Journal of Hospital Infection

Volumn 77, Issue 2, 2011, Pages 113-117

  Buehlmann, M ^a   Bruderer, T ^a   Frei, R ^a   Widmer, A F ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Decolonisation; Eradication; Extended spectrum lactamases

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORHEXIDINE; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; NITROFURANTOIN; PAROMOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CLINICAL PROTOCOL; ENTEROBACTERIACEAE; ERADICATION THERAPY; ESCHERICHIA COLI; FEMALE; HUMAN; INFECTION CONTROL; INTESTINE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; RECTUM; SINGLE DRUG DOSE; THROAT; URINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; COHORT STUDIES; DISINFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SWITZERLAND; YOUNG ADULT;

EID: 78951491039     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.09.022     Document Type: Article

References (30)

1. Paterson D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Infect Control 2006, 34(5 Suppl. 1):S20-28.
2. Pitout J.D., Nordmann P., Laupland K.B., Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005, 56:52-59.
3. Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Entero-bacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
4. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., Fishman N.O. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001, 32:1162-1171.
5. Harris A.D., McGregor J.C., Johnson J.A., et al. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007, 13:1144-1149.
6. Martinez J.A., Aguilar J., Almela M., et al. Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia. J Antimicrob Chemother 2006, 58:1082-1085.
7. Skippen I., Shemko M., Turton J., Kaufmann M.E., Palmer C., Shetty N. Epidemiology of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case-control study from a tertiary hospital in London. J Hosp Infect 2006, 64:115-123.
8. Rodriguez-Bano J., Navarro M.D., Romero L., et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 2004, 42:1089-1094.
9. Canton R., Novais A., Valverde A., et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14(Suppl. 1):144-153.
10. Goossens H., Grabein B. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). Diagn Microbiol Infect Dis 2005, 53:257-264.
11. Harris A.D., Kotetishvili M., Shurland S., et al. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition?. Am J Infect Control 2007, 35:97-101.
12. Lavilla S., Gonzalez-Lopez J.J., Miro E., et al. Dissemination of extended-spectrum beta-lactamase-producing bacteria: the food-borne outbreak lesson. J Antimicrob Chemother 2008, 61:1244-1251.
13. Mesa R.J., Blanc V., Blanch A.R., et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage). J Antimicrob Chemother 2006, 58:211-215.
14. Bellini C., Nahimana I., Senn L., Wenger P., Francioli P., Zanetti G. Enterobacteriaceae producing extended-spectrum beta-lactamase: duration of carriage and implication for surveillance 2008, Abstract ECCMID 2008, Barcelona, Spain.
15. Kola A., Holst M., Chaberny I.F., Ziesing S., Suerbaum S., Gastmeier P. Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period. J Hosp Infect 2007, 66:46-51.
16. Buehlmann M., Frei R., Fenner L., Dangel M., Fluckiger U., Widmer A.F. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol 2008, 29:510-516.
17. Paterson D.L., Singh N., Rihs J.D., Squier C., Rihs B.L., Muder R.R. Control of an outbreak of infection due to extended-spectrum beta-lactamase-producing Escherichia coli in a liver transplantation unit. Clin Infect Dis 2001, 33:126-128.
18. Troche G., Joly L.M., Guibert M., Zazzo J.F. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol 2005, 26:161-165.
19. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. Management of multidrug-resistant organisms in healthcare settings. Am J Infect Control 2006, 35(Suppl. 2):S165-S193. HICPAC, CDC.
20. Garner J.S., Jarvis W.R., Emori T.G. CDC definition for nosocomial infections. Am J Infect Control 1988, 16:128-140.
21. NCCLS WPa. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. M7-A5. 2000.
22. Potz N.A., Colman M., Warner M., Reynolds R., Livermore D.M. False-positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 beta-lactamase. J Antimicrob Chemother 2004, 53:545-547.
23. Paterson D.L., Ko W.C., Von Gottberg A., et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001, 39:2206-2212.
24. Valverde A., Grill F., Coque T.M., et al. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol 2008, 46:2796-2799.
25. Marschall J., Muhlemann K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol 2006, 27:1206-1212.
26. Macfarlane M., Leavy A., McCaughan J., Fair R., Reid A.J. Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol. J Hosp Infect 2007, 65:231-236.
27. Lartigue M.F., Zinsius C., Wenger A., Bille J., Poirel L., Nordmann P. Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland. Antimicrob Agents Chemother 2007, 51:2855-2860.
28. Doi Y., Paterson D.L., Egea P., et al. Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 2010, 16:33-38.
29. Lautenbach E., Strom B.L., Bilker W.B., Patel J.B., Edelstein P.H., Fishman N.O. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2001, 33:1288-1294.
30. Filippini M., Masiero G., Moschetti K. Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy 2006, 78:77-92.